EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access

Extracranial-Intracranial Bypass and Risk of Stroke and Death in Patients With Symptomatic Artery Occlusion

Yan Ma, Tao Wang, Haibo Wang, Sepideh Amin-Hanjani, Xiaoguang Tong, Jiyue Wang, Zhiyong Tong, Dong Kuai, Yiling Cai, Jun Ren, Donghai Wang, Lian Duan und 11 weitere

JAMA · 22.08.2023 · 330 (8) · 704

DOI: 10.1001/jama.2023.13390 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JAMA, erschienen am 22.08.2023. Verfasst von Yan Ma und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Xuanwu Hospital, China International Neuroscience Institute, Capital Medical University, National Center for Neurological…. Hauptthemen laut MEDLINE: Arteriosclerosis, Cerebral Revascularization, Ischemic Attack, Transient, Stroke. Die Arbeit wurde bisher 105-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Prior trials of extracranial-intracranial (EC-IC) bypass surgery showed no benefit for stroke prevention in patients with atherosclerotic occlusion of the internal carotid artery (ICA) or middle cerebral artery (MCA), but there have been subsequent improvements in surgical techniques and patient selection.

Objective

To evaluate EC-IC bypass surgery in symptomatic patients with atherosclerotic occlusion of the ICA or MCA, using refined patient and operator selection. Design, Setting, and Participants This was a randomized, open-label, outcome assessor–blinded trial conducted at 13 centers in China. A total of 324 patients with ICA or MCA occlusion with transient ischemic attack or nondisabling ischemic stroke attributed to hemodynamic insufficiency based on computed tomography perfusion imaging were recruited between June 2013 and March 2018 (final follow-up: March 18, 2020).

Interventions

EC-IC bypass surgery plus medical therapy (surgical group; n = 161) or medical therapy alone (medical group; n = 163). Medical therapy included antiplatelet therapy and stroke risk factor control. Main Outcomes and Measures The primary outcome was a composite of stroke or death within 30 days or ipsilateral ischemic stroke beyond 30 days through 2 years after randomization. There were 9 secondary outcomes, including any stroke or death within 2 years and fatal stroke within 2 years.

Results

Among 330 patients who were enrolled, 324 patients were confirmed eligible (median age, 52.7 years; 257 men [79.3%]) and 309 (95.4%) completed the trial. For the surgical group vs medical group, no significant difference was found for the composite primary outcome (8.6% [13/151] vs 12.3% [19/155]; incidence difference, −3.6% [95% CI, −10.1% to 2.9%]; hazard ratio [HR], 0.71 [95% CI, 0.33-1.54]; P = .39). The 30-day risk of stroke or death was 6.2% (10/161) in the surgical group and 1.8% (3/163) in the medical group, and the risk of ipsilateral ischemic stroke beyond 30 days through 2 years was 2.0% (3/151) and 10.3% (16/155), respectively. Of the 9 prespecified secondary end points, none showed a significant difference including any stroke or death within 2 years (9.9% [15/152] vs 15.3% [24/157]; incidence difference, −5.4% [95% CI, −12.5% to 1.7%]; HR, 0.69 [95% CI, 0.34-1.39]; P = .30) and fatal stroke within 2 years (2.0% [3/150] vs 0% [0/153]; incidence difference, 1.9% [95% CI, −0.2% to 4.0%]; P = .08). Conclusions and Relevance Among patients with symptomatic ICA or MCA occlusion and hemodynamic insufficiency, the addition of bypass surgery to medical therapy did not significantly change the risk of the composite outcome of stroke or death within 30 days or ipsilateral ischemic stroke beyond 30 days through 2 years. Trial Registration ClinicalTrials.gov Identifier: NCT01758614

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArteriosclerosisCerebral RevascularizationIschemic Attack, TransientStrokePlatelet Aggregation InhibitorsFemaleHumansMaleMiddle AgedCarotid Artery DiseasesCarotid Artery, InternalInfarction, Middle Cerebral ArteryIntracranial ArteriosclerosisIschemic StrokeMiddle Cerebral ArteryPerfusion ImagingSingle-Blind MethodTomography, Emission-ComputedCombined Modality Therapy

Substanzen

Platelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Department of Neurosurgery, Xuanwu Hospital, China International Neuroscience Institute, Capital Medical University, National Center for Neurological Disorders, Beijing, China.
  • Peking University Clinical Research Institute, Peking University First Hospital, Beijing, China.
  • Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China.
  • Cerebrovascular and Skull Base Surgery, Department of Neurological Surgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio.
  • Department of Neurosurgery, Huanhu Hospital, Tianjin, China.
  • Department of Neurosurgery, Liaocheng People's Hospital, Shandong First Medical University and Shandong Academy of Medical Sciences, Liaocheng City, Shandong, China.

Zitieren

APA

Ma, Y., Wang, T., Wang, H., Amin-Hanjani, S., Tong, X., Wang, J., Tong, Z., Kuai, D., Cai, Y., Ren, J., Wang, D., Duan, L., Maimaitili, A., Hang, C., Yu, J., Bai, X., Powers, W. J., Derdeyn, C. P., Wu, Y., …, & CMOSS Investigators (2023). Extracranial-Intracranial Bypass and Risk of Stroke and Death in Patients With Symptomatic Artery Occlusion. JAMA, 330(8), 704. https://doi.org/10.1001/jama.2023.13390

Vancouver

Ma Y, Wang T, Wang H, Amin-Hanjani S, Tong X, Wang J, et al. Extracranial-Intracranial Bypass and Risk of Stroke and Death in Patients With Symptomatic Artery Occlusion. JAMA. 2023;330(8):704. doi:10.1001/jama.2023.13390

BibTeX
@article{Ma2023,
  author = {Ma, Yan and Wang, Tao and Wang, Haibo and Amin-Hanjani, Sepideh and Tong, Xiaoguang and Wang, Jiyue and Tong, Zhiyong and Kuai, Dong and Cai, Yiling and Ren, Jun and Wang, Donghai and Duan, Lian and Maimaitili, Aisha and Hang, Chunhua and Yu, Jiasheng and Bai, Xuesong and Powers, William J and Derdeyn, Colin P and Wu, Yangfeng and Ling, Feng and Gu, Yuxiang and Jiao, Liqun and CMOSS Investigators, CMOSS Investigators},
  title = {Extracranial-Intracranial Bypass and Risk of Stroke and Death in Patients With Symptomatic Artery Occlusion},
  journal = {JAMA},
  year = {2023},
  volume = {330},
  number = {8},
  pages = {704},
  doi = {10.1001/jama.2023.13390}
}
Kostenlos starten →